InvestorsObserver
×
News Home

Should Biotechnology Stock Cytokinetics, Inc. (CYTK) Be in Your Portfolio Friday?

Friday, June 24, 2022 12:04 PM | InvestorsObserver Analysts

Mentioned in this article

Should Biotechnology Stock Cytokinetics, Inc. (CYTK) Be in Your Portfolio Friday?

The 69 rating InvestorsObserver gives to Cytokinetics, Inc. (CYTK) stock puts it near the top of the Biotechnology industry. In addition to scoring higher than 86 percent of stocks in the Biotechnology industry, CYTK’s 69 overall rating means the stock scores better than 69 percent of all stocks.

Overall Score - 69
CYTK has an Overall Score of 69. Find out what this means to you and get the rest of the rankings on CYTK!

What do These Ratings Mean?

Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. InvestorsObserver allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 69 would rank higher than 69 percent of all stocks.
These scores are not only easy to understand, but it is easy to compare stocks to each other. You can find the best stock in an industry, or look for the sector that has the highest average score. The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.

What's Happening With Cytokinetics, Inc. Stock Today?

Cytokinetics, Inc. (CYTK) stock is down -3.52% while the S&P 500 is up 2.37% as of 12:04 PM on Friday, Jun 24. CYTK is down -$1.67 from the previous closing price of $47.47 on volume of 483,375 shares. Over the past year the S&P 500 is down -8.93% while CYTK is up 103.10%. CYTK lost -$3.22 per share the over the last 12 months. Click Here to get the full Stock Report for Cytokinetics, Inc. stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App